Medical device CEO resigns over conduct allegations after 7 months in role

Merit Medical, a Utah-based medical device company with more than 7,000 employees, has announced the resignation of its president, Joseph C. Wright. The move is effective Jan. 3, 2025.

Wright resigned after unspecified allegations regarding his conduct were brought to light. Merit performed an independent investigation of the allegations, which it said were not related to the company’s “operations or financial performance.” 

Wright was first named Merit’s president back in May after spending 19 years with the company in a number of leadership positions, including chief commercial officer. 

Fred P. Lampropoulos, who founded Merit back in 1987 and now serves as its chairman and CEO, will once again be the company’s president once Wright’s resignation is official. Lampropoulos had previously announced his intention to retire at the end of 2025. 

Merit Medical’s expanding electrophysiology portfolio

Merit develops, manufactures and distributes medical devices used in multiple healthcare specialties, including cardiology, radiology, oncology, critical care and endoscopy. In October, the company announced a revenue of $339.8 million for the third quarter of 2024, up 7.8% compared to 2023. 

Merit recently agreed to purchase Cook Medical’s end-to-end lead management portfolio for approximately $210 million. The transaction was announced in September and then finalized on Nov. 1. 

“We believe this transaction will strengthen our fast-growing, high-margin electrophysiology and cardiac rhythm management business with the addition of differentiated products and an established commercial infrastructure,” Lampropoulos said at the time.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.